Rheumnow Podcast

New Steroid Rules for Lupus - Dr. Michelle Petri Management of CKD in Lupus Nephritis - Dr. HJ Anders HCQ Levels and Adherence - Dr. Nathalie Costedoat-Chalumeau Lupus Nephritis Guidelines - a debate - Drs. Michelle Petri and Maria Dall'Era Nephrologists Approach to Lupus Nephritis - Dr. Brad Rovin Voclosporin and Steroids in Lupus Nephritis - Dr. Jack Cush

In this webinar, panelists discussed issues such as congenital heart block, lupus nephritis treatment, teratogenic risks including conception on mycophenolate, antiphospholipid syndrome, hypertension management including the differential diagnosis of preeclampsia, practical guidance on pregnancy planning, and optimizing outcomes for patients with lupus. Panelists: Dr. Megan Clowse, Dr. Lisa Sammaritano, Dr. Jill Buyon, Dr. Jack Cush

- QD286: Early Lupus (Dr. Jack Cush) https://youtu.be/zzpC397FhZ0 - QD287: A Different Strategy to Tackle Non-adherence (Dr. Megan Clowse) https://youtu.be/28fhFVM7QRc - QD288: Tackling Lupus Pregnancies (Dr. Bella Mehta) https://youtu.be/zZiGyUTaEF0 - QD289: All Swells that Ends Well (Dr. Sheila Reyes) https://youtu.be/ipnSRchKLqY

- QD282: SLE Get Ready (Dr. Jack Cush) https://youtu.be/UWNAxiuwZro - QD283: Rhupus (Dr. Jack Cush) https://youtu.be/OJUfylWJf4c - QD284: The Dilemma of MMF Without Birth Control (Dr. Megan Clowse) https://youtu.be/Q1yJrQXyJSU - QD285: Young SLE (Dr. Jack Cush) https://youtu.be/KigLAeOZciY

- QD279: Hyperpigmentation in Lupus (Dr. Jack Cush) https://youtu.be/xA9nvuadhCg - QD280: Polar Opposite Approaches for Lupus (Dr. Eric Dein) https://youtu.be/zCnF1rgAapk - QD281: Refractory Renal SLE (Dr. Jack Cush) https://youtu.be/dHS8etnZsRw

Dr. Jack Cush reviews the news and journal reports from RheumNow.com - including views on the vagus nerve, NPSLE and CAR-T mania.

In this one-hour webinar, panelists discussed antiphospholipid syndrome, including diagnosis, labs, treatment approaches and more. Panelists Dr. Shruti Chaturvedi, Dr. Jason Knight, Dr. Cassy Sims and Dr. Jack Cush

Dr. Jack Cush reviews the news, journal and regulatory reports from this week on RheumNow.com. Interesting trends and results with prednisone in lupus, cannabis in RA and opioid deaths too!

Discussion of the diagnosis, management, and latest insights into cutaneous manifestations of SLE. Panelists: Dr. Victoria P. Werth, Dr. Matilda Nicholas; Dr. Anthony Fernandez; and, Dr. Christopher Richardson.

Dr. Jack Cush reviews the news, journal reports and lupus highlights from the past week on RheumNow.com. Triple positivity, the gut and CRPS, and hope for better outcomes with Vitamin D therapy.

In this first webinar of RheumNow's Lupus Unlocked campaign, Journal Club discussed two articles: Efficacy and Safety of Obinutuzumab in Active Lupus Nephritis. Furie R, et al. NEJM. 2025 Feb 7. doi: 10.1056 Efficacy and safety of voclosporin versus placebo for lupus nephritis (AURORA 1) Rovin BH. Lancet. 2021 May 29;397(10289) Speakers: Brad Rovin, MD Richard Furie, MD Jack Cush, MD

Dr. Jack Cush reviews the news, articles and drug approvals from the past week on RheumNow.com. This podcast marks the beginning of our Lupus Campaign called "Lupus Unlocked: Keys to Mastery". This months campaign on Lupus is sponsored by Aurinia.

Listen as coinvestigator and rheumatologist Dr. Andrea Rubbert-Roth reviews this Phase 3 trial of a JAKi in patients with giant cell arteritis. Dr. Rubbert-Roth discusses the latest results, including efficacy and safety outcomes.

Dr. Jack Cush reviews the news and journal reports from the past week on RheumNow.com. Should we believe the reviews and metanalyses?

Dr. Jack Cush reviews the news and Journal reports from this week on RheumNow.com. Osteoarthritis patients have unique risks and synovial fluid WBC numbers can tell you when to worry about septic arthritis in gout and pseudogout patients.

Dr. Jack Cush reviews the news, journal reports and regulatory approvals from this past week on RheumNow.com

Dr. Jack Cush reviews the news and journal reports from this past week on RheumNow.com. **Correction: a Tweet from 3/18 podcast, had incorrect information. Late Breaking abstract from 2025 Amer. Acad. Dermatology (AAD) on the Phase 3 ICONIC-LEAD study showed J&J's oral IL-23 inhibitor (icotrokinra) was superior to PLACEBO (not deucravacitinib as reported) in skin clearance (65% vs 8%) & PASI90 (50% v 4%) at Wk 16 (NOT 15) in 684 moderate-to-severe plaque PsO pts https://buff.ly/dMbTbML

Rheumatologist Dr. Walter Maksymowych discusses the role of biomarkers in RA care, with a focus on 14-3-3eta as a modifiable marker for diagnosis and monitoring disease progression.

Dr. Jack Cush reviews the news and journal reports from this past week on RheumNow.com

Dr. Jack Cush reviews the news and journal reports from this past week on RheumNow.com. Listen in for 2 new case questions - Ask Cush Anything.

Dr Jack Cush and his podcast friends are out to change the world. Here is his weekly review of the news and journal reports from the past week on RheumNow.com

Hear from rheumatologist Stanley J. Naides MD, FACP, FACR, as he details the clinical features of autoimmune myositis, the associated phenotypes and autoantibodies, plus the methodologies and testing options to support a myositis diagnosis.

Two leading rheumatologists share insights into why RF levels are important to consider when identifying treatment options for patients with RA.

Dr. Jack Cush reviews the news, journal reports and regulatory actions from the past week on RheumNow.com

Dr. Jack Cush reviews the news and journal reports from the past week on RheumNow.com. Opioid deaths are down, IL-33 levels are up and Weight loss is in the news again this week!

Dr. Jack Cush reviews the news and journal articles from the past week on RheumNow.com

Dr. Jack Cush reviews highlights from RheumNow Live 2025 held in Dallas, TX on Feb. 8-9, 2025

Dr. Jack Cush reviews the news, regulatory and journal reports from the past week on RheumNow.com

QD276 - New Palmoplantar Psoriasis and PsA https://youtu.be/GJmY27xA1MM QD277 - dsDNA without Lupus https://youtu.be/daL70sBh8ss QD278 - Recurrent Acute Oligoarthritis https://youtu.be/Xp2ZNBPN1o8 Features Dr. Jack Cush. QD Clinics - lessons from the clinic, sponsored by RNL2025 in Dallas, TX; Feb 8 & 9, 2025 Register at RheumNow.live

Dr. Jack Cush reviews the news and journal reports from the past week on RheumNow.com. We have two call-in cases on "Ask Cush Anything" Be sure to join in the fun at RNL 2025 next weekend - Gong Show Karaoke; what will you sing?

QD Clinic 273 - ANA Negative Lupus https://youtu.be/g0W9aBRuDcQ Pregnant ANA negative SLE (?) patients with Sjogrens and FM - what to do? QD274 - Undiagnosed Autoinflammatory https://youtu.be/hUkYi1gKJOM Autoinflammatory or Still's disease - does this matter? QD275 - Past DIagnoses https://youtu.be/1f4HYhvVGNA When patients cling to a past diagnosis. QD Clinics - lessons from the clinic, sponsored by RNL2025 in Dallas, TX; Feb 8 & 9, 2025 Register at RheumNow.live

Dr. Jack Cush reviews the news and journal reports from RheumNow.com. He features Dr. Charity Dean, the Keynote speaker at RheumNow Live 2025 and why she is an inspiration. Register for RheumNow Live 2025 and hear Keynote Speaker, Dr. Charity Dean -- RheumNow.live

Dr. Jack Cush reviews the news and journal reports from the past week on RheumNow.com; and pays homage to colleagues who passed away in 2024.

QD clinics - lessons from the Clinic brought to you by RheumNow Live 2025 QD 269 CREST or More? https://youtu.be/GSBfr2S9iL4 Is this CREST or Diffuse PSS? Features Dr. Jack Cush. QD270 Acute Neck & Back Pain https://youtu.be/qWTGvqL9-wY Acute onset febrile, polyarthritis, neck and low back pain Features Dr. Jack Cush. QD271 - Treating Overlap with ILD https://youtu.be/eR7O-oy_O_g Polyarthritis, ILD, Dermatomyositis - how to treat? Features Dr. Jack Cush. QD272 - Natural RA https://youtu.be/Ie1u-_KqxVE PsO/PsA patient avoiding DMARDs and Biologics, and wants Natural therapies Features Dr. Jack Cush. QD Clinics - lessons from the clinic, sponsored by RNL2025 in Dallas, TX; Feb 8 & 9, 2025 Register at RheumNow.live

Dr. Jack Cush brings in the new year with a review of the latest from RheumNow.com

Dr. Jack Cush reviews the journal reports from the past week on RheumNow.com. Highlights are summarized by three songs: "Stairway to Heaven", "Youre No Good", and "How Long (has this been going on)". From 2.9.2024

Dr. Jack Cush reviews the news and journal reports from this past week on RheumNow.com RheumNow Live 2025: Register now! RheumNow.live

Dr. Jack Cush reviews the news and journal reports from the past week on RheumNow.com Join us at RheumNow Live February 8 & 9 in Dallas, TX! https://t.co/7WawLxwBLP

This year at ACR24, the RheumNow faculty and reporters were prolific, generating 800 Tweets, 56 written articles, 117 Videos and 28 podcasts – all in 4 days! You can best review and learn ACR 2024 by A) Rheumatology Roundup; b) TOPIC Panel podcasts; and c) Topic podcasts. This weeks notable citations on RheumNow.com

Discover the latest advancements in targeting the IL-17 pathway from the ACR Annual Meeting! This expert-led panel will delve into groundbreaking research and therapeutic strategies for managing rheumatic diseases.

Join us for an in-depth discussion about the ACR Annual Meeting! This expert panel will explore the latest research and clinical applications of JAK and TYK inhibitors in managing rheumatic diseases. Stay informed about the cutting-edge therapies shaping the future of rheumatology care. Dr. Janet Pope London, Ontario Dr. David Liew Melbourne Dr. Michael Putman Milwaukee

Panelists: Dr. Jonathan Kay, Dr. Jiha Lee, Dr. Eric Dein and Dr. Jeffrey Spark

Tune in for an engaging discussion at the ACR Annual Meeting! This expert panel will explore the latest breakthroughs and trends in Psoriatic Arthritis(PsA) research and management, providing actionable insights for clinicians and researchers.

Highlight presentations from ACR 2024 in Washington, DC Covered abstracts include: - Dr. Kavanaugh 1679 Amplified & biomarkers 0082 Enthesitis Pathology & IL-23 1553 TLR 7/8 inhibitors in SLE 995 Carbon footprint to injectables L20 ARTHUR DIANA Automated US 1132 VEGA (Combo Rx – see also 2640, 1460, 1393) 1745 Statin use in Oral Surveillance - Dr. Cush 458 Seronegative RA fate L19 Emapalumab in Stills disease ACR 2024 updated guidelines on lupus nephritis 2580 Ianalumab in SLE 2259 Anti-Obesity Meds in RA 2657 Mortality with starting/stopping steroids 0774 TAPIR study in GCA 1697 PMR MODE study

Join us as we dive into expert insights from the ACR Annual Meeting! This special panel will focus on the latest research and advancements in Spondyloarthritis (SpA), featuring thought leaders in the field. Dr. Marina Magrey Cleveland Dr. Lihi Eder Toronto Dr. Sheila Reyes Phillipines Dr. Adela Castro Memphis

A New ACR Cancer Survival in RA "Changing Mindsets about Methotrexate Side Effects" Control RA, Build Stronger Bones Cumulative Steroid Use and Cardiovascular Events Disease Activity in RA-ILD Do TNFis and JAKis Prevent Cancer!? Estimating Inflammation, Damage and Patient Distress Finding the Right Combination Therapy in RA Implantable Vagus Nerve Stimulator for RA Is Frequent Lab Monitoring Necessary? Long Term Follow up from APIPPRA Metabolic Dysregulation and RA Interstitial Lung Disease Native Americans with RA Die Young Paraoxonase-1: Possible Biomarker for Progression to RA Pred Softly: Steroids Predicting Flares in Rheumatoid Arthritis RA Roundup: Is LDA Inappropriate? What about Statins for JAKs? RA Treatment Adherence: Is decision making really shared? RA: One JAK to Rule Them All? Sonelokimab in PsA: Phase 2 Data Treat-to-Target Improves Fertility in Women with RA Treatment Considerations for RA-ILD Treatment Strategies in RA Use of AI in Hand Ultrasound Scoring Vaccine Responses:The DMARD Counts What's New in Relapsing Polychondritis? What's The State of Biosimilars?

A New ACR Anti IL-17 on Entheseal Biopsy in PsA axSpA: Impact of TNF and IL-17 in Patients with Prior TNF Exposure Best Things I Saw Today in PsA Cycling vs Switching after TNFi Failure in axSpA Improvements in Pain and Fatigue in Bimekizumab Long-term Safety Profile of Bimekizumab in axSpA and PsA Sonelokimab in PsA: Phase 2 Data Treating SpA

A New ACR Best Things I Saw Today in PsA Do TNFis and JAKis Prevent Cancer!? Hold or continue JAKi and IL-17 when receiving COVID boosters? JAK-pot! How fast do DMARDs work? JAKi Studies at ACR Poly-treatment of Polymyalgia Rheumatica? RA Roundup: Is LDA Inappropriate? What about Statins for JAKs? RA: One JAK to Rule Them All? SELECT-GCA: Efficacy and Safety of Upadacitinib "SELECT-GCA: Upadacitinib in Giant Cell Arteritis" SELECTing the right patients: upadacitinib in GCA So really, are JAKs Safe? Summary of JAKi Studies The Case for JAKi in PMR The Real Value of JAKi is Beyond RA When, What and How Long to Treat GCA & PMR Worried about CV Risk and JAKi? What about the Steroids?

A Fibroblast Renaissance A New ACR A useful urinary biomarker for lupus nephritis ANA+ and no Autoimmune Disease? Check the liver CAR-T Therapy and Lupus Cyclophosphomide vs Mycophenolate vs Tacrolimus in Lupus Nephritis Evaluating ANA Patterns and Titers with AI Neuropsychiatric Lupus: The Forgotten Symptoms The 2024 ACR Guidelines for Lupus Nephritis Vaccine Responses:The DMARD Counts What is MCTD? The Great Debate